Shares are to be offered to private and institutional investors in Germany and Luxembourg through a public offering. Outside of these countries, the plan is to offer the shares to institutional investors via private placements. In the U. Securities Act of The planned IPO is the logical next step.
|Published (Last):||27 February 2008|
|PDF File Size:||15.27 Mb|
|ePub File Size:||20.71 Mb|
|Price:||Free* [*Free Regsitration Required]|
Shares are to be offered to private and institutional investors in Germany and Luxembourg through a public offering. Outside of these countries, the plan is to offer the shares to institutional investors via private placements.
In the U. Securities Act of The planned IPO is the logical next step. In these areas, it focuses on market segments and regions with sustained high growth potential. In , Evonik generated more than 80 percent of its chemicals sales in fields in which it ranks among the market leaders. The company derives benefits from its integrated technology platforms, which undergo continuous development.
These platforms generate growth and cost benefits and represent significant market entry barriers for competitors. Furthermore, Evonik has a balanced spectrum of business activities and end-markets and a balanced regional presence. Further strengths are proximity to customers and market-oriented research and development. It continued to build on these very good results in the first quarter of After adjustment for the carbon black business, which was divested in , Evonik expects that full-year sales in will be slightly higher than in and that the operating results will probably be in line with or slightly above the excellent level reported for Based on the present timeline, publication of the securities prospectus and the start of trading in the shares is expected to take place before the summer break.
Morgan are mandated. Disclaimer These materials must not be published, distributed or transmitted in the United States, Canada, Australia or Japan. These materials do not constitute an offer of securities for sale or a solicitation of an offer to purchase securities the "Shares" of Evonik Industries AG the "Company" in the United States, Germany or any other jurisdiction.
The Shares of the Company may not be offered or sold in the United States absent registration on exemption from registration under the U. Securities Act of , as amended the "Securities Act". The Shares of the Company have not been, and will not be, registered under the Securities Act. This publication constitutes neither an offer to sell nor a solicitation to buy securities.
The offer will be made solely by means of, and on the basis of, a securities prospectus which is to be published. An investment decision regarding the publicly offered securities of Evonik Industries AG should only be made on the basis of the securities prospectus. In the United Kingdom, this document is only been distributed to and is only directed at persons who i are investment professionals falling within Article 19 5 of the Financial Services and Market Act Financial Promotion Order as amended the "Order" or ii are persons falling within Article 49 2 a to d of the Order high net worth companies, unincorporated associations, etc.
This document is directed only at Relevant Persons and must not be acted on or relied on by persons who are not Relevant Persons. Any investment or investment activity to which this document relates is available only to Relevant Persons and will be engaged in only with Relevant Persons. In so far as forecasts or expectations are expressed in this investor relations news or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties.
Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.
EVONIK IPO PROSPECTUS PDF
Faumi Prior to the Acquisition, the Company had no operations. Further strengths are proximity to customers and market-oriented research and development. When we file a patent application, it is usually filed pdospectus all countries with active competition, where we have existing customers. The redemption notice was given at least 30 days in advance of the redemption date and is irrevocable, subject to the closing of this offering and evnoik Refinancing having occurred. We obtain a considerable portion of our raw materials and energy from selected key suppliers. In periods with significant market turmoil and tightened credit availability, we expect to experience difficulty in collecting accounts receivable, pricing pressure and reduced global business activity.
Tinyu PDF Me
In addition to supporting our operations, we use our systems to collect and store confidential and sensitive data, including orospectus about our business, our customers and our employees. Dollar-denominated instruments more expensive. We believe that our current operational efficiency, flexibility and reliability give us a competitive foundation for future value-creation. Currently, we are in negotiations with Korean labor unions, in connection with a recent Korean Supreme Court evnoik pursuant to which recurring fixed bonus payments to Korean employees in certain circumstances constitutes ordinary wages. Our global supply network allows us to quickly establish credentials with customers in new locations and those seeking consistent prospecgus across regions. We dvonik seek to improve the profitability of our rubber carbon black business by developing applications in higher margin markets for mechanical rubber goods and specialty tire requirements.
Evonik’s owners and Evonik confirm IPO plan
Nagami Additionally, it may be necessary to enter into hedging arrangements in the future to reduce the impact of raw material, energy price volatility currency and exchange rate fluctuation. We are subject to volatility in the costs and availability of raw materials and energy, which could decrease our margins and adversely affect our business, financial condition, propectus of operations and cash flows. Listing — Evonik Industries — Specialty Chemicals Competition is based on price, product innovation, product quality, distribution capability, and industry and customer knowledge. In the event of an increase in inflation, we may seek to increase the sales prices of our products in order to maintain prospeectus margins, however such increases may not be accepted by our customers, may not be sufficient to compensate for the negative impact of inflation or may decrease demand for our products and our volume of sales. Furthermore, a number of our customers and suppliers rely on access to credit to adequately fund their operations, which may also be limited due to dislocations in the credit markets.